Brandywine Global Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-414,084	Closed	-$2.51M	–	700
2023 Q4	$2.51M	Sell	414,084 -43,250	-9%	-$193K	0.02%	519
2023 Q3	$1.93M	Buy	457,334 +55,654	+14%	+$208K	0.02%	553
2023 Q2	$1.25M	Buy	+401,680	New	+$856K	0.01%	607
2022 Q4	–	Sell	-188,559	Closed	-$381K	–	724
2022 Q3	$381K	Sell	188,559 -9,083	-5%	-$25.5K	﹤0.01%	687
2022 Q2	$629K	Sell	197,642 -10,825	-5%	-$39.2K	0.01%	649
2022 Q1	$869K	Buy	208,467 +11,744	+6%	+$52K	0.01%	633
2021 Q4	$942K	Hold	196,723	–	–	0.01%	585
2021 Q3	$1.05M	Buy	196,723 +25,808	+15%	+$130K	0.01%	570
2021 Q2	$875K	Sell	170,915 -4,898	-3%	-$27.8K	0.01%	576
2021 Q1	$1.18M	Sell	175,813 -9,375	-5%	-$52K	0.01%	553
2020 Q4	$846K	Buy	+185,188	New	+$821K	0.01%	533